|
To meet the challenge goal to eliminate the suffering and death due to cancer by 2015 there must be a linking of technology development and biomedical research to create opportunities to accelerate our understanding of the genetic, molecular and cellular mechanisms that determine the development and behavior of diseases such as cancer.
The purpose of the ad hoc subcommittee is to advise the NCI's Director and senior leadership on the development of application of biomedical technologies to cancer research, the nature and structure of centers and consortia (node) that integrate research, development and applications, and mechanisms that could facilitate that development of a network to integrate the Discovery-Development continuum and accelerate the Delivery of new agents and technologies. The ad hoc subcommittee will establish working and focus groups to explore the potential contribution of current and future advanced technologies in the development of strategies to preempt cancer at various stages. The subcommittee will be responsible for providing input in formulating a strategy for the creation of a National Advanced Biomedical Technologies Initiative that will ultimately have an impact on reducing the burden of cancer and other related diseases.
|
